Results 191 to 200 of about 12,853 (286)
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich +10 more
wiley +1 more source
Resolving selfish and spiteful interdependent conflict. [PDF]
Stewart AJ, Pilgrim C, Raihani NJ.
europepmc +1 more source
ABSTRACT The social motivation theory hypothesizes that autistic individuals' experience diminished social motivation due to reduced social reward, social orienting, and social maintaining. Low social motivation has been linked to increased vulnerability to internalizing difficulties within this population.
Katie Lindsay‐Webb +3 more
wiley +1 more source
Hamilton's rule meets the Hamiltonian: kin selection on dynamic characters [PDF]
europepmc +1 more source
The Price equation and the unity of social evolution theory. [PDF]
Lehtonen J.
europepmc +1 more source
ABSTRACT Autism Spectrum Disorder (ASD) is characterized by certain difficulties in emotion‐related processing. Recent research using electroencephalography (EEG) to measure somatosensory evoked potentials during emotion perception has shown reduced embodiment of emotional expressions in autistic compared to neurotypical individuals, independently from
Martina Fanghella +5 more
wiley +1 more source
Increasing the succinate yield in Actinobacillus succinogenes by fumigation of H2 in a bioreactor
Abstract The microbial conversion of CO2 into value‐added chemicals offers a promising and scalable route for sustainable bioproduction, particularly under mild reaction conditions and with technically straightforward reactor configurations. Actinobacillus succinogenes, a natural succinate producer, can fix CO2 through anaplerotic carboxylation but its
Julian Tix +3 more
wiley +1 more source
Altruism and natural selection in a variable environment. [PDF]
Dos Santos M +4 more
europepmc +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source

